Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Sebocytes play a key role in controlling androgen levels in human skin.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hair loss in postmenopausal woman caused by ovarian issue.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Low iron levels are linked to more hair loss in non-menopausal women.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

A woman's male-like physical changes were caused by two rare ovarian conditions.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.